Danenberg K - Search Results

1

Dynamic changes in RAS gene status in circulating tumour DNA: a phase II trial of first-line FOLFOXIRI plus bevacizumab for RAS-mutant metastatic colorectal cancer (JACCRO CC-11).

Sunakawa Y, Satake H, Usher J, Jaimes Y, Miyamoto Y, Nakamura M, Kataoka M, Shiozawa M, Takagane A, Terazawa T, Watanabe T, Ishiguro K, Tanaka C, Takeuchi M, Fujii M, Danenberg K, Danenberg PV, Lenz HJ, Sekikawa T, Ichikawa W. Sunakawa Y, et al. Among authors: danenberg k. ESMO Open. 2022 Jun;7(3):100512. doi: 10.1016/j.esmoop.2022.100512. Epub 2022 Jun 7. ESMO Open. 2022. PMID: 35688061 Free PMC article. Clinical Trial.

2

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.

Shirota Y, Stoehlmacher J, Brabender J, Xiong YP, Uetake H, Danenberg KD, Groshen S, Tsao-Wei DD, Danenberg PV, Lenz HJ. Shirota Y, et al. Among authors: danenberg pv, danenberg kd. J Clin Oncol. 2001 Dec 1;19(23):4298-304. doi: 10.1200/JCO.2001.19.23.4298. J Clin Oncol. 2001. PMID: 11731512

3

TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials.

Grimminger PP, Shi M, Barrett C, Lebwohl D, Danenberg KD, Brabender J, Vigen CL, Danenberg PV, Winder T, Lenz HJ. Grimminger PP, et al. Among authors: danenberg pv, danenberg kd. Pharmacogenomics J. 2012 Oct;12(5):404-11. doi: 10.1038/tpj.2011.29. Epub 2011 Jul 26. Pharmacogenomics J. 2012. PMID: 21788964

4

Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib).

Wilson PM, Yang D, Azuma M, Shi MM, Danenberg KD, Lebwohl D, Sherrod A, Ladner RD, Zhang W, Danenberg PV, Trarbach T, Folprecht G, Meinhardt G, Lenz HJ. Wilson PM, et al. Among authors: danenberg pv, danenberg kd. Pharmacogenomics J. 2013 Oct;13(5):410-6. doi: 10.1038/tpj.2012.23. Epub 2012 Jun 5. Pharmacogenomics J. 2013. PMID: 22664478 Clinical Trial.

5

Quantitative determination of the ratio of mutated to normal ras genes in the blood of leukemia patients by allele-specific PCR.

Horikoshi T, Lenz HJ, Danenberg K, Koch OM, Bertino JR, Danenberg PV. Horikoshi T, et al. Among authors: danenberg k, danenberg pv. Leuk Res. 1994 Sep;18(9):693-702. doi: 10.1016/0145-2126(94)90069-8. Leuk Res. 1994. PMID: 7934145

6

Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.

Leichman CG, Lenz HJ, Leichman L, Danenberg K, Baranda J, Groshen S, Boswell W, Metzger R, Tan M, Danenberg PV. Leichman CG, et al. Among authors: danenberg k, danenberg pv. J Clin Oncol. 1997 Oct;15(10):3223-9. doi: 10.1200/JCO.1997.15.10.3223. J Clin Oncol. 1997. PMID: 9336359

7

High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil.

Metzger R, Danenberg K, Leichman CG, Salonga D, Schwartz EL, Wadler S, Lenz HJ, Groshen S, Leichman L, Danenberg PV. Metzger R, et al. Among authors: danenberg k, danenberg pv. Clin Cancer Res. 1998 Oct;4(10):2371-6. Clin Cancer Res. 1998. PMID: 9796967

8

Pharmacogenetic profiling of Aurora kinase B is associated with overall survival in metastatic colorectal cancer.

Pohl A, Azuma M, Zhang W, Yang D, Ning Y, Winder T, Danenberg K, Lenz HJ. Pohl A, et al. Among authors: danenberg k. Pharmacogenomics J. 2011 Apr;11(2):93-9. doi: 10.1038/tpj.2010.18. Epub 2010 Apr 6. Pharmacogenomics J. 2011. PMID: 20368716

9

Activity of thymidylate synthetase and its inhibition by 5-fluorouracil in highly enzyme-overproducing cells resistant to 10-propargyl-5,8-dideazafolate.

Danenberg KD, Danenberg PV. Danenberg KD, et al. Among authors: danenberg pv. Mol Pharmacol. 1989 Aug;36(2):219-23. Mol Pharmacol. 1989. PMID: 2528057

10

Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival.

Lenz HJ, Leichman CG, Danenberg KD, Danenberg PV, Groshen S, Cohen H, Laine L, Crookes P, Silberman H, Baranda J, Garcia Y, Li J, Leichman L. Lenz HJ, et al. Among authors: danenberg pv, danenberg kd. J Clin Oncol. 1996 Jan;14(1):176-82. doi: 10.1200/JCO.1996.14.1.176. J Clin Oncol. 1996. PMID: 8558194 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters